2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with Carcinoma, Ductal, Breast in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alaoui-Jamali, MA; Bijian, K; Lougheed, C; Riccio, K; Su, J; Wu, JH; Xu, B; Yu, H | 1 |
1 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Cells, Cultured; Female; Focal Adhesions; Humans; MCF-7 Cells; Mice; Mice, SCID; Molecular Targeted Therapy; Morpholines; Purines; Xenograft Model Antitumor Assays | 2013 |